ClinicalTrials.Veeva

Menu

Comparison Between Using 10min CTG in Fetal Monitoring Instead of 30min Monitoring in Low Resources Overcrowded Hospitals.

A

Assiut University

Status

Not yet enrolling

Conditions

Labor Active Dilated Cm
Normal Pregnancy

Study type

Observational

Funder types

Other

Identifiers

NCT07250620
10min CTG monitoring accuracy.

Details and patient eligibility

About

Cardiotocography (CTG) is a cornerstone of intrapartum fetal monitoring but requires a minimum of 30 minutes for a reliable trace, creating a significant bottleneck in high-volume, low-resource settings like Egypt As it is time-consuming and resource intensive. This leads to delays in care and increased workload for healthcare providers. A shortened, yet accurate, CTG protocol could drastically improve workflow and resource allocation without compromising fetal safety.

Full description

In Egypt, labor wards in tertiary hospitals are often overcrowded with limited CTG machines and midwives. The requirement of a minimum 30-minute CTG trace creates bottlenecks in care and increases staff workload. Previous studies suggest that the first 10 minutes of a CTG may capture the essential features of fetal well-being. If validated, a shortened CTG could improve efficiency in high-volume maternity units without compromising neonatal outcomes. Using umbilical venous pH as the gold standard for fetal acid-base status, this study will directly compare the diagnostic accuracy of a 10-minute versus a 30-minute CTG protocol in low-risk laboring women. The aim is to evaluate whether a 10-minute CTG tracing is non-inferior to the standard 30 minute CTG in fetal assessment and predicting fetal acid-base status (umbilical venous pH) in term, low-risk pregnancies during the active first stage of labor.

Enrollment

200 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Singleton pregnancy.
  • Gestational age ≥ 37 weeks.
  • Vertex presentation.
  • Active first stage of labor (cervical dilation ≥ 4 cm).
  • Low-risk pregnancy (no hypertension, diabetes, IUGR, or other significant complications).

Exclusion criteria

  • • Multiple gestation.

    • Known major fetal anomaly.
    • Non-vertex presentation.
    • Indication for continuous CTG (e.g., meconium-stained liquor, antepartum hemorrhage).
    • Maternal refusal.

Trial design

200 participants in 1 patient group

women full term pregenancy in active stage of labor

Trial contacts and locations

0

Loading...

Central trial contact

Seif Ahmed Ali, PHD; Soliman Mohamed Alazhary, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems